September
Page Twenty Five
Corticosteroid-Sparing Immunosuppression in Liver
Transplantation
Issues in Cirrhosis and Liver Transplantation
Recurrence of Hepatitis C Virus Infection
After Liver Transplantation
CME/CE
Hepatic Iron Overload Reduces Survival After Liver
Transplant
July-August
Page Twenty Four
Technical
considerations in liver transplantation: What a hepatologist needs to know
(and every surgeon should practice)
Aug 15 2005
Peginterferon Alfa-2b Plus Ribavirin Elicits Sustained
Response in Decompensated HCV Patients
Bone Loss after
Liver Transplants Can Be Prevented
Accelerating regimen of interferon plus ribavirin
reduces post-transplantation HCV relapse
Living donor liver
transplantation
Post-Transplant Treatment
July 18 2005
May-June
Page Twenty Three
Liver
Transplantation for Hepatocellular Carcinoma
June 05 2005
Hepatitis C after liver transplantation: risk factors,
outcomes, and treatment.
June 05 2005
Issues in Liver Transplantation
May
15 2005
Peginterferon and
Ribavirin Therapy Does Not Increase Acute Rejection Risk Post Liver
Transplantation
May
05 2005
Peginterferon
Alfa-2b (PegIntron) plus Ribavirin in the Treatment of Post-liver Transplant
Recurrent Hepatitis C
May
05 2005
Preclinical
Evaluation of Two Neutralizing Human Monoclonal Antibodies against HCV: A
Potential Treatment to Prevent HCV Re-infection in Liver Transplant Patients
March
Page Twenty Two
Should we treat
patients with chronic hepatitis C on the waiting list?
Liver
transplantation for hepatitis C: how to control the virus?
March 23 2005
Page Twenty One
A Possible
Link Between Hepatitis C Virus Infection and Type-2 Diabetes in Renal
Diseases and Transplantation
Roche initiates
trial in post-transplant hepatitis
A new study on the effect of donor age on survival and
recurrence of hepatitis C after liver transplantation found that it
influenced short-term survival, but had no long-term effect.
March 23 2005
Post-Transplant HCV Treatment
Determinants of Transplant Surgeons' Willingness to
Provide Organs to
Patients Infected with HBV, HCV or HIV
March 03 2005
A Comparison of Liver Transplantation Outcomes in the
Pre- vs Post-MELD Eras
Feb 28 2005
A 65% SVR Rate
Reported in Liver Transplant Patients Treated with Standard Interferon
Alfa-2b or Peginterferon Alfa-2b (Peg-Intron) in Combination with Ribavirin |
